Assessment of ICP in Idiopathic Intracranial Hypertension Using Transocular Ultrasound and Transcranial Doppler

Idiopathic Intracranial Hypertension Clinical Trial

Official title:

Assessment of Raised Intracranial Pressure in Patients With Idiopathic Intracranial Hypertension by Optic Nerve Sheath Diameter and Transcranial Doppler Measurements

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04314128
• Other study ID #: H-19029542
• Status: Completed
• Phase: N/A
• Start date: January 1, 2020
• Est. completion date: February 1, 2023

Study information

• Verified date: March 2023
• Source: Danish Headache Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Idiopathic Intracranial Hypertension (IIH) is a rare disease, primarily affecting overweight females of child-bearing age. Patients suffer from increased intracranial pressure (ICP), typically resulting in headaches, visual disturbances and bilateral papilledema, pulsatile tinnitus and cognitive deficits. The disease is difficult to diagnose, treat and monitor. The only current method of measuring the ICP in day-to-day clinical practice is by lumbar puncture. This procedure is invasive, and often painful for the patient. There is an unmet need of methods that can reliable measure or estimate ICP in a non-invasive manner. Ultrasound is one such potential method, and the aim of this study is to investigate the use of ocular ultrasound and transcranial doppler to measure or estimate ICP.

Description:

This study is a prospective cohort study. Investigators plan to include 50 patients in whom the IIH-diagnosis is suspected. Patients are referred from general practitioners, neurologists or ophthalmologists to the Danish Headache Center or admitted to the Neurology ward when the IIH diagnosis is suspected. As part of an established routine clinical work-up to establish the diagnosis of IIH, all patients will undergo (according to the Friedman criteria) the following examinations: A) 1. An interview (history taking) and clinical examination 2. Routine laboratory tests (blood tests) 3. Ophthalmological examination 4. Lumbar puncture with measurement of the ICP 5. Magnetic resonance imaging (MRI) of the brain Additionally the following investigations will be performed at baseline (before and after lumbar puncture): B) Transorbital sonography (TOS) C) Transcranial Doppler When the patient is seen at the clinic for their regular follow-up visits the same measurements will be done. A control group of healthy participants (NR=25) will be included in whom TOS (B) and TCD (C) will be performed in order to compare the values between the patient group (IIH) and control group. Controls will be included to match the patients according to BMI, age and gender. All ultrasound images- and films will be saved, and evaluated by a blinded investigator.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 78
• Est. completion date: February 1, 2023
• Est. primary completion date: February 1, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

PATIENT GROUP (ARM 1):

Inclusion Criteria:

• Age 18-65
• Patients in whom the IIH diagnosis is suspected/or confirmed
• The diagnosis of migraine with or without aura or tension-type headache is allowed as a comorbid headache type.
• Participants must read and understand the Danish language, or have an official interpreter present to be able to understand the work-up and sign the participation consent for the study

Exclusion Criteria:

• Pregnant or breastfeeding females
• Patients who do not need a diagnostic lumbar puncture at the time of evaluation
• Patients treated with acetazolamide, topiramate or furosemide for IIH or suspected IIH before inclusion in the study (baseline)
• Any other primary or secondary headache diagnosis than migraine with or without aura or tension type headache as a comorbid disorder
• Patients in whom the examination cannot be performed due to anatomical reasons such as severe head dysmorphia or severe ophthalmological diseases
• Participants with secondary causes of raised intracranial pressure, or patients that have been treated for such (e.g. brain tumor, hydrocephalus, stroke or severe head injury)
• Participants with known atherosclerotic disease or known heart disease CONTROL GROUP (ARM 2):

Inclusion criteria:

• Age 18-65
• Healthy persons who do not suffer from any form of primary headache except infrequent tension-type headache
• Participants must read and understand the Danish language or have an official interpreter present to be able to sign the participation consent for the study.

Exclusion criteria:

• Pregnant or breastfeeding females
• Participants in whom the examination cannot be performed due to anatomical reasons such as severe head dysmorphia or severe ophthalmological diseases

Related Conditions & MeSH terms

• Hypertension
• Idiopathic Intracranial Hypertension
• Intracranial Hypertension
• Pseudotumor Cerebri

Intervention

Diagnostic Test:
• TOS and TCD
TOS: Transorbital sonography TCD: Transcranial Doppler

Locations

Country	Name	City	State
Denmark	Danish Headache Center	Glostrup	Region Hovedstaden

Sponsors (1)

Lead Sponsor	Collaborator
Danish Headache Center

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Correlation between opening pressure and ONSD	Optic nerve sheath diameter (ONSD) potential correlation with opening pressure.	1 year
Primary	Correlaton between opening pressure and ONSD/ETD ratio	ONSD/ETD (external transverse diameter) ratio and potential correlation with opening pressure.	1 year
Primary	Comparison of ONSD in IIH and healthy controls	Comparison of ONSD in patients with elevated ICP (IIH) and healthy controls, age- sex and BMI matched.	1 year
Secondary	Optic disc elevation	Optic disc elevation measured by ultrasound in IIH compared with healthy controls	1 year
Secondary	ONSD diameter on MR c in patients with IIH	ONSD and correlation with ONSD on orbital MRI.	1 year
Secondary	Changes in the optic nerve (ONSD)	Changes in ONSD after 1 month	1 month
Secondary	Changes in the optic nerve (ONSD)	Changes in ONSD after 6 months	6 months
Secondary	Changes in the optic nerve (ODE)	Changes in ODE (optic disc elevation) after 1 month	1 month
Secondary	Changes in the optic nerve (ODE)	Changes in ODE(optic disc elevation) after 6 months	6 months
Secondary	TCD (PI - pulsatility index) in patients with IIH	Evaluation of pulsatility index for major intracranial arteries (PI) using doppler ultrasound in patients with raised intracranial pressure (IIH) compared with normal values.	2 years
Secondary	TCD (MBFV - mean blood flow velocity) in patients with IIH	Evaluation of mean blood flow velocity (MBFV) for major intracranial arteries using doppler ultrasound in patients with raised intracranial pressure (IIH) compared with normal values.	2 years
Secondary	TCD (RI - resistance index) in patients with IIH	Evaluation of resistance index (RI) for major intracranial arteries using doppler ultrasound in patients with raised intracranial pressure (IIH) compared with normal values.	2 years
Secondary	Neuro-ophthalmological evaluation of papilledema versus ultrasound evaluation of the optic nerve	Papilledema and the optic nerve is usually evaluated by neuro-ophthalmologists in patients with IIH. Investigators will compare this evaluation with the assessment made by TOS ultrasound.	2 years